Cancer care is expensive. Cancer care provided by practice organizations varies in total spending incurred by patients and payers during treatment episodes and in quality of care, and this unnecessary variation contributes to the high cost.
C ancer care is complex, variably delivered, and usually conducted in an ambulatory setting by physician-led teams. Care delivery teams operate at the intersection of basic biology, clinical medicine, and patient emotional needs. The complexity and variation in care delivery creates opportunities to identify attributes of ambulatory oncology practices that deliver high-value care, that is, high-quality care at a relatively low total cost. Because value-based paymentsimplementation of the Medicare Access and Children's Health Insurance Program Reauthorization Act, the Oncology Care Model, and Accountable Care Organizations-are already rewarding high-value institutions, a better appreciation of the attributes of high-value oncology care is timely. 1 Combinations of claims data with cancer registry and clinical data can broadly identify high-and low-value care, but smaller units of care delivery, such as an ambulatory oncology practice, are not well studied. [2] [3] [4] Measuring and defining value includes quantitative measures of the total cost of care and measures of quality. 5 One measure of ambulatory cancer care is provided by the American Society of Clinical Oncology's Quality Oncology Practice Initiative (QOPI) 6 and the associated voluntary QOPI certification program. 7 To identify qualitative attributes of groups that deliver high-value cancer care, we used the "positive deviance" technique. Positive deviance detects superior existing solutions that can then be adopted to produce similar results. 8 Positive deviance has identified fresh approaches to patient activation as well as physician engagement and clinical care after myocardial infarction 9-11 and has been used previously by our group.
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Our exploratory hypothesis-generating study started with quantitative methods to identify positive deviant practices, meaning practices that ranked favorably compared with their peers on low mean total spending per treatment episode and that also scored highly on ambulatory quality measures. We then applied qualitative methods to identify potentially transferable attributes of high-value care.
Methods

Quantitative Methods to Select Potential High-Value Practices
The Hutchinson Institute for Cancer Outcomes Research and Anthem Inc provided data that enabled the generation of a sample of oncology practices in western Washington state and 2 Midwestern states. Practices were defined by their unique federal tax identification numbers; when the same tax identification number was associated with several sites of care, the largest site was selected. Sites, practices, practice organizations, oncologists, and oncology practices are hereinafter referred to as practices. Participation in the study was voluntary. The institutional review board at Stanford University determined that the present study was exempt from institutional review board review and waived the need for participant informed consent.
The Hutchinson Institute for Cancer Outcomes Research developed a measure of quality that included adherence to 4 of the Choosing Wisely treatment recommendations (as an indicator of quality) 13 (eTable 1 in the Supplement), spending (including health insurance claims data from Premera Blue Cross), and tumor staging information from tumor registries.
3 Data were used from 3225 patients whose care was attributed to 16 practices from January 2007 through May 2014. 3 Potential high-value practices were in the lowest third of the spending distribution and were considered "wise choosers," whereas comparator practices were in the middle third on spending. As a marker of quality, QOPI-certified practices were selected.
14 In another region of the United States, Anthem Inc identified 32 973 episodes of care provided by 206 practices in Ohio and Indiana from July 2010 through July 2012. Anthem Inc used the Optum Episode Treatment Group, a case-mix adjustment and episode-building system that uses routinely collected inpatient and ambulatory claims data (eg, claims for physician services, chemotherapy and associated administration, and imaging) to compare mean total spending per treatment episode among health care practices. 15 Based on the Optum
Episode Treatment Group output, potential high-value practices were identified with observed to expected costs below the mean and potential comparator organizations with cost and CIs overlapping the mean. Because Choosing Wisely performance data on these practices were not available, the American Society of Clinical Oncology's QOPI certification program was used such that potential practices were further winnowed to those that were QOPI-certified.
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In total, 11 oncology practices remained after excluding those practices that did not predominantly provide medical oncology services, those with substantial missing data (eg, omitted physician codes), or those with too few patients attributed to the practice physicians. Of these, 4 high-value practices, which were designated positive deviant practices, and 3 comparator practices were assessed in our qualitative study. Additional details are in the eMethods in the Supplement.
Site Visit Protocol
Among others, two of us (D.W.B., a senior medical oncologist, and B.P., a qualitative researcher) conducted 2-day site visits from June 2, 2015, through October 3, 2015. Physicians, advanced practice providers (including licensed nurse practitioners and licensed physician assistants), nurses, medical support, administrative office personnel, and practice leaders and
Key Points
Question What are the attributes of "positive deviant" oncology practices that deliver high-quality cancer care at low total cost? Findings In this analysis using mixed quantitative and qualitative methods and site visits to 7 US oncology practices with structured interview questionnaires, 13 attributes were identified that likely contributed to high-value cancer care. Five attributes most clearly distinguished oncology practice sites that ranked favorably on value.
Meaning Attributes of high-value positive deviant oncology practices can be implemented in other care systems and their contribution to value studied. managers were interviewed. A structured interview tool, designed prior to site visits and containing questions covering clinical, nonclinical, and quality management topics, was used uniformly. The interview questions were shared with practice personnel prior to the visit, and the site visitors recorded extensive interview notes. Questions probed care delivery methods, staff roles and functions, patient services provided, cultural norms, and diagnostic and surveillance testing use. The site visit team also solicited interviewee opinions regarding attributes that could affect quality and total spending. All interviewers and interviewees were blinded to practice status (ie, high value or comparator).
Qualitative Analysis of Interviews
A separate team debriefed the site-visit team within 48 hours of a site visit. The site-visit team also prepared a written report summarizing the interviews.
A 5-stage framework approach, developed for applied qualitative research, 16 was used to identify attributes potentially responsible for high value. In the first familiarization stage, interviewee "mentions" of features contributing to high value and high-quality care were identified. (Mentions from all 7 site visits were treated equally regardless of the practice's classification.) Based on these mentions, in the second stage, a thematic framework was identified (eg, "treatment planning and goal setting") as given in the first column of Table 1 . For stage 3, site-visit mentions were grouped into "attributes," and each attribute was categorized into the appropriate theme to identify distinctive attributes among the practices. Each attribute and its implementation details were charted in stage 4. For the final stage, distinct attributes that might explain the high value were summarized, synthesized, and identified. Attributes were subdivided into patient-and practice-centered themes. Attributes found in low-spending practices and in comparator practices were then tallied. Recommendations for theory-based content analysis 17 were followed to achieve thematic saturation, that is, identifying all themes from interview data. The practices to study and the roles for interviewers and interviewees were established a priori, and the same structured interview questions and interview guide were used for all practices. A minimum of 10 interviewees were included from each practice. The mentions and attributes were organized and presented using cumulative frequency graphs to enhance the transparency and verifiability of the decision that saturation had been achieved and to address complex or multifaceted descriptions. The analysis continued until no new themes emerged. The interview results were coded by 3 independent coders (M.K.S., B.P., and C.L.) from the debriefing team.
Review of Findings by an Oncology Expert Physician Panel
The results uncovered in the qualitative aspect of this study were further refined by a recruited expert panel of experienced oncologists. Using a modified Delphi process, the panel scored each attribute for its potential to lower mean spending per episode without compromising quality of care. A composite of their scores was then computed.
Results
Attributes of High-Value Practices
The characteristics of the 7 practices that agreed to participate and were visited by one of our site-visit teams are given in eTable 2 in the Supplement. The team identified 13 distinct practice attributes that may have affected care cost and quality. These practice attributes were grouped into the following 5 themes and are given in Table 1 : (1) .'" Oncologists and diagnostic radiologists explicitly discussed the most efficient testing route to patient goals (eg, using the same imaging tests for both cancer staging and radiotherapy planning) and chose those diagnostic tests with the highest utility. This process was described by clinicians as a "conservative" or "less is more" approach. Adoption and adherence to this conservative testing approach was reinforced by routine group discussions and by coordinating test use during tumor boards and case conferences.
Treatment Planning: Setting Goals After Explicit Discussion on the Benefits, Limits, and Consequences Physicians and other team members emphasized conducting discussions early after initial diagnosis, during the first or second office visit, or after significant clinical events (eg, cancer recurrence) to incorporate input from the conversations into the treatment plan and to "set realistic goals." Sufficient time was allotted to ensure the patient understood the treatment, the available patient support services, and the availability of concurrent palliative care (curative treatment of treatable conditions, including infections; symptomatic treatment of dyspnea and pain, as well as end-of-life care). The physician and other team members revisited these discussions at follow-up visits to ensure that treatments were continuously aligned with patient goals.
Support for the Patient Journey
Proactive support for patients during predictably stressful periods (eg, cancer relapse or unexpected scan results) was also unique to the high-value practices. A single staff member was often the "point person" or "go-to person" to assist patients in understanding their disease and learning to navigate the health care system. Often trained as a nurse, this point person frequently met with the patient (usually at each office visit), offering tips on self-management and help with a range of common stressful issues, including financial and transportation assistance and access to services that provide social and emotional support.
Care Team Functions at the Highest Level of Competence and License
The use of experienced oncology nurses and other nononcologist care providers was another often-mentioned attribute. Nurses worked via protocol to provide clinical assessments and management suggestions (typically in response to inbound telephone calls); to triage nonscheduled, urgent, or emergent patient evaluation; and to offer management by nonphysician clinical staff (usually advanced practice providers, including nurse practitioners, advanced practice nurses, or physician assistants) or to nononcology physicians.
External Context
Close affiliation with a large and generally hospital-based health system or with a health plan that employed physicians was also a feature of high-value practices. However, the oncology practice unit was small and cohesive and retained its distinct identity within a larger system. The affiliated larger systems provided a broad range of staff to support functions such as quality measurement, human resources, pharmacy, navigation, and social work.
Discussion
Themes Unique to High-Value Practices
In this qualitative analysis of high-value practices, we found 5 unique attributes, which we categorized within 4 themes. Our expert oncology panel ranked 3 of these as highly likely to contribute to a practice's high quality and low cost of care ( Table 2) .
Theme 1: Treatment Planning and Goal Setting
Physician restraint in the use of laboratory testing and imaging was often expressed as "we don't order tests if the result won't change the treatment plan" or shown by the preplanned use of 1 imaging procedure for both diagnostic and radiotherapy planning. In addition, global treatment planning and realistic goal setting were found to engage patients and families along the cancer journey. Engaged patients and families were considered under the care of the team. Care teams "added value by talking more." Early introduction of palliative care services and normalizing palliative care-"this is the way we always do it"-is another high-value attribute. Normalizing palliative care mitigates the sometimes negative connotations of the end-of-life or hospice care associated with palliative care. An example of this successful attribute was the following: "[(O)ur palliative care team has] taken care of a family member of almost all of our medical staff, and they have experienced firsthand the benefits we provide." Our methodology could not distinguish among the many aspects of palliative care to determine which had the greatest impact.
Theme 3: Care Team Functions at the Highest Level of Competence and License Experienced, well-trained nurses performed clinical assessments and made protocol-based patient self-management recommendations. If a patient needed urgent care, these nurses would often direct patients to an on-site ambulatory care facility. This facility was generally in the chemotherapy infusion area or was to a contracted urgent care facility. The goal was to avoid unnecessary, expensive, and inconvenient emergency department visits.
In addition, advanced practice providers often provided chemotherapy symptom management, survivorship care, and palliative care. This system enabled physicians to use their skills to focus on complex clinical problems and their time to develop deeper patient relationships and to facilitate shared decision making by patients and families.
Theme 4: External Context
Although our exploratory study focused on attributes of care delivery, the smaller units of care delivery that surfaced as positive deviants on value often benefitted from administrative infrastructure (eg, a common electronic health record platform, human resources, and compliance personnel) supplied by an associated health system. The combination of "small care" and "big administrative support" may enable care teams to be nimbler in decision making, more open to adoption of best practices, or better at relational coordination.
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Role of Qualitative Research in Determining Value
Efforts to measure and improve quality and increase the value in health care, such as through the QOPI, have focused on improving adherence to processes of care. Implicit in this quality improvement effort is the assumption that clinical trial outcomes (eg, improved overall survival, disease-free survival improvements, and reduced toxicity) can be translated into processes, and adherence to processes will improve care and lead to better outcomes. [22] [23] [24] While process measures and guideline adherence have utility and can be quantified, they provide little guidance on potentially important and nonobvious attributes of care delivery. Qualitative research methods, such as interviews of positive deviant oncology practices, can expand our understanding of how value is created by care teams.
Limitations
The results from our small, hypothesis-generating study are insufficient to support widespread adoption of the attributes that we reported. In addition, our results are strictly applicable only to QOPI participants, who represent approximately 15% of practicing US medical oncologists. High-quality positive deviant oncology practices who do not participate in a QOPI were missed Our results can be viewed as those from a "training" data set; organizations that choose to implement our findings should carefully study-as a "validation" set-the contribution of our results in achieving better health, quality care, and low cost. Validation should preserve the validity of our discriminatory measures (eg, standard interview questions, interviewers blinded to practice cost status, multiple practice personnel interviewed across multiple job functions, and thematic saturation) and verify and examine with more granularity the contribution to costs associated with the practice attribute. Validation might also include identifying other care practices that discriminate excellent from good to confirm the validity of the important attributes provided in Table 1 . Our results will inform design of larger, confirmatory qualitative studies as well as of larger value-based data sets.
Conclusions
Organizations facing increased pressure to lower health care spending and improve quality of oncology care can view this study as an additional source of insight, until readily transferable attributes of care are tested and available to inform more refined system designs. Changes to the decision-making culture of laboratory testing and diagnostic imaging will require physician leadership and participation and administrative and implementation science support. Upgrading staff roles and improving care efficiency will require a system redesign. Patient-centered redesign of care is valuable and should be central to any change management effort. Our preliminary study has identified attributes of some of the most valuable care in the United States. Insurers are seeking ways to motivate clinicians to provide effective care at lower cost. To this end, Medicare is trying out alternate payment mechanisms, such as bundled care, accountable care organizations, and the Center for Medicare and Medicaid Innovation's "Oncology Care Model," which is testing alternative payment strategies in almost 200 US practices. Given these payment changes, a list of interventions that reduce costs and improve quality of care and quality of life for patients with cancer will soon become required reading for oncologists. This issue of JAMA Oncology contains an article by Blayney and colleagues that describes such a list. 4 The authors studied 4 oncology practices from Washington State and 3 from the Midwest. All were among the 15% of oncology practices certified by a program to promote highquality cancer care (QOPI). The criterion for including a practice was the average cost of care for a patient with cancer. Four practices were in the lower part of the distribution of cancer care costs (and therefore designated "high-value"), and the other 3 were from the middle of the distribution (designated "averagevalue"). Guided by a structured survey form, 2 coauthorsblinded to practice cost status and quality scores-interviewed clinicians and administrators from each practice to identify practice designs and routines that might reduce costs. From the interview notes, the coauthors used qualitative methods to identify specific practice attributes that might explain high-value care. They then tallied the frequency of these practice routines in the high-value and average-value practices.
The authors identified 15 high-value practice characteristics and classified them into 5 themes (see their Table 1 ). In the highvalue practices, 7 of the high-value characteristics occurred in every practice, and 7 occurred in all but 1 of the practices. Eleven of the 15 characteristics occurred in only 1 or none of the 3 average- The practices participating in our study, including the practice's description of their organizational type, the number of physicians and number of medical oncologists, and their estimate of their payer mix. Note that all studied practices provided high quality care as defined by the American Society of Clinical Oncology's (ASCO) Quality Oncology Practice Initiative (QOPI) Certification Program (2) or by high levels of adherence to ASCO's "Choosing Wisely" care processes (1) . CERC and HICOR collaborated to convene a panel of national experts to propose a methodology using existing HICOR measures to assess variation in oncology performance. Both Choosing Wisely adherence and total cost of care measures were used to identify high performers and average performers.
Choosing Wisely Adherence Measures and Composite Development
Based on the expert panels advice, we worked with HICOR to develop a standardized composite building on HICOR's adherence measures for 4 of the 5 2012 ASCO Choosing Wisely Recommendations (eTable 1). We did not include the measure related to prostate cancer on advice from the expert panel, as urologists rather than medical oncologists typically lead care for these patients.
Patients were assigned to their primary oncology provider by aggregating cancer related claims over a recommendation specific period of interest to define an episode of care (e.g. breast cancer staging was +/ 2 months of diagnosis). Analysts at HICOR removed all but the first radiation oncology claim and removed claims from diagnostic centers (imaging and pathology).
Patients were attributed to the Tax ID number (TIN) with the highest claim count. Clinics required at least 5 attributed patients to be included in the analysis.
The medical group's overall observed/expected (O/E) episode ratio was calculated by comparing the adherence rate attributed to the medical group to their expected rate. The expected rate for a practice was defined as the average clinic rate for each measure. A composite score for each clinic was derived by dividing the weighted observed/expected ratio by the clinic volume.
Exemplar groups were in the top quartile on the adherence composite. Comparator groups were drawn from the middle quintile of the distribution.
Cost Measures and Composite Development
Using the panel's guidance, we sought to develop a cost composite that assessed total cost of care related to the time periods relevant for 3 of the 5 Choosing Wisely measures.
To analyze costs, we developed a time based episode to capture total cost of care related to each CW measure. Costs were measured using all costs paid by the insurer during the period of interest for each measure described in eTable 1.
For total cost of care, in addition to excluding prostate staging we also excluded breast cancer surveillance. We excluded breast cancer surveillance as we were not able to risk adjust for age and co morbidities, which could result in justified variations in the cost of treatment for this measure which has a long time period and covers a time when cancer costs are likely to be secondary to other medical costs.
The medical group's overall observed/expected (O/E) episode cost ratio was calculated by comparing the total cost of episodes attributed to the medical group to their expected cost. The expected cost for a medical group is defined as the average episode cost. A composite score for each clinic was derived by dividing the weighted observed/expected ratio by the clinic volume.
Exemplar groups were in the top tercile on the cost composite. Comparator groups were drawn from the middle quintile of the distribution.
Cost Quality Matching, Desk Audit, & Purposeful Sampling Two groups performed in the top tercile on adherence and the lowest tercile on costs (we identified these as "wise choosers" or high value practices) and one performed at the median on adherence and cost (we identified this practice as a comparator). None had any reputational issues. Our pool was too small to do any purposeful sampling. We were able to recruit and visit all three groups. Quality To assess quality we partnered with ASCO s quality improvement registry the Quality Oncology Practice )nitiative QOP) QOP) provides a system for practices to measure processes of care semiannually using retrospective medical record abstraction methodology ASCO shared QOP) data for de identified practices in )ndiana or Ohio After a review of the data and consultation with experts we decided to use QOP) certification as a threshold for quality because quality performance between QOP) certified sites was not well differentiated As a result the distinction between high performers and average performers in )ndiana and Ohio is based solely on cost performance All of the sites visited have reached the threshold for quality set by ASCO as part of its quality improvement program as described below
The QOP) Certification Program QCP recognizes medical oncology and hematology practices that perform well on QOP) measures For practices that opt into the program QCP provides a year certification if the practice submits data for required modules breast colorectal non small cell lung cancer care at the end of life symptom toxicity management during one collection round follows QOP) sampling methodology and meets chart sample size targets complies with the certification standards based on the ASCO ONS standards for safe chemotherapy administration and obtains an overall quality score of based on the combined score on measures Nationwide there are QOP) Certified practices with six in )ndiana and seven in Ohio Ten of these QOP) certified practices were found within our cost data (owever only eight of them met our cost criteria Cost Quality Matching Desk Audit Purposeful Sampling From our original pool of practices tiered as cost high value practices and comparators we found that three exemplar practices and five comparator practices were also QOP) Certified
At the desk audit stage we removed one comparator practice because of a provider identification issue We had originally identified the practice within our own cost data as a comparator but we found that only one physician within the practice had QOP) certification Upon further investigation we saw that the one QOP) certified physician did not show up in our data and instead that we had identified the practice based on his colleagues cost performance We dropped this site from our pool None of the sites had reputational issues
